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OBJECTIVES: Negative-pressure wound therapy has been widely adopted to reduce the complexity of treating a
broad range of acute and chronic wounds. However, its cost is high. The objective of this study was to evaluate
the following two different methods of negative-pressure wound therapy in terms of healing time: a low-cost
method of negative-pressure wound therapy (a pressure stabilizer device connected to a hospital wall-vacuum
system with a gauze-sealed dressing, USP) and the standard of care (vacuum-assisted closure, VAC).
METHODS: This is a randomized, controlled, non-inferiority, unblinded trial. Patients admitted with complex
injuries to a trauma center in a public referral hospital who were indicated for orthopedic surgery were
randomized to a USP or VAC group. The primary outcome was the time required to achieve a ‘‘ready for surgery
condition’’, which was defined as a wound bed with healthy granulation tissue and without necrosis or purulent
secretion. Wound bed area contraction, granulation tissue growth and the direct costs of the dressings were
secondary outcomes.
RESULTS: Variation in area and granulation tissue growth were essentially the same between the systems, and
healing time was equal between the groups (p=0.379). In both systems, serial debridement increased wound
area (p=0.934), and granulation tissue was also increased (p=0.408). The mean treatment cost was US$ 15.15 in
the USP group and US$ 872.59 in the VAC group.
CONCLUSIONS: For treating complex traumatic injuries, USP was non-inferior to and less expensive than VAC.
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’ INTRODUCTION
Negative-pressure wound therapy (NPWT) was approved
by the FDA (Food and Drug Administration) in 1996 and
has since then been widely adopted as a treatment for a
broad range of wounds (1). NPWT has many indications,
including both acute and chronic injuries (2), and has
simplified the treatment of wounds for doctors, and
nurses (2).
Some authors have suggested that NPWT could be used
in traumatic wounds as a bridge to definitive closure when
primary closure is not possible after or between debridement
procedures (3-5). The most substantial disadvantage of this
procedure is its cost, which remains high and generally
unaffordable over prolonged use (2,6). As mentioned by the
authors of a University of Chicago Medical Center (UCMC)
study: ‘‘this financial burden can limit the use of NPWT in
settings and situations where budgets are constrained, parti-
cularly in public hospitals and for patients who are under-
insured or uninsured (not to mention in developing countries
globally). From the health care providers’ standpoint, our
interest in coming up with more cost-effective alternatives isDOI: 10.6061/clinics/2017(12)04
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obvious; such efforts can ultimately translate to increased
availability/accessibility of therapies for patients in various
settings. Furthermore, for issues as prevalent as wound
care management, they can also have a significant financial
impact on hospitals and the health care system as a
whole’’ (7). In 2007, the University of São Paulo (USP)
developed a low-cost NPWT that used a pressure stabilizer
device (Curavac VX 200, Ventrix Health Innovation, Brazil),
connected to a hospital wall-vacuum and a gauzed-sealed
dressing. This system will henceforth be referred to
as ‘‘USP’’. However, so far, no randomized clinical trial
has compared USP NPWTwith a commercially available
vacuum-assisted closure device (VAC system, KCI, San
Antonio, TX, USA). We therefore performed the present
study.
Although different NPWT systems are available, VAC
was chosen as the standard of care based on feasibility. The
VAC system was the first NPWT to be approved by the FDA
since 1996, and it remains the leader in sales worldwide
and the only one available in the University of São Paulo
Hospital.
The primary objective was to determine whether the
‘‘USP’’ method is non-inferior to the standard of care, VAC,
with respect for the time required to achieve a ‘‘ready for
surgery’’ status in trauma patients.
The following were secondary outcomes: changes in wound
size, granulation tissue growth and the overall associated costs
of the dressings between the two systems.
’ METHODS
Design, setting and ethics
A prospective, randomized, non-inferiority trial was designed
to compare two different negative-pressure devices used for
wound closure. The trial occurred at the Orthopedics and
Traumatology Institute of Hospital das Clínicas, Faculdade
de Medicina, Universidade de São Paulo (FMUSP), in
São Paulo, Brazil. The study was previously approved by the
University of São Paulo Ethics Committee (0371/11), and
the protocol is registered in the ClinicalTrials.gov Registry.
Participants and sampling
All consecutive patients admitted to one public university
hospital (Hospital das Clínicas, University of São Paulo) with
acute wounds caused by open fractures inflicted by high-
energy trauma between September 2013 and July 2016 were
eligible for this study. To be included in this study, the cases
had to involve severe wounds that would not close on the
first attempt (without surgery).
The exclusion criteria were diabetes mellitus, diagnosed
peripheral vascular disease, chronic use of steroids, coagu-
lopathies and cancer.
The sample size was calculated to allow a comparison of
the time required to achieve a wound bed that is ready for
surgery. Since we expected USP and VAC to have similar
effects on wound bed preparation time, we used a non-
inferiority testing strategy. The non-inferiority margin was
set at 5%, meaning that the data would support the non-
inferiority of USP if the number of days necessary to be ready
for surgery was no more than 5% greater in the USP than
in the VAC group. To achieve 80% statistical power and a
significance (alpha) level of 5%, the estimated required sample
size was 36 treatments in each group.
Interventions
In the VAC group, GranuFoam sponge (Kinetics Concepts,
Inc., San Antonio, TX, USA) was applied to the wounds
and sealed using an occlusive plastic dressing. Continuous
suction at 120 mmHg was then initiated.
In the USP group, a 100% cotton sterile gauze dressing was
applied to the wound. Then, an 18-Fr polyvinyl nasogastric
tube was placed in the center of the dressing and sealed in
place using a transparent adhesive and a sterile, waterproof
film (Opsite Drape, Smith & Nephew, Kingston Upon Hill,
UK). The dressing was connected to the hospital’s con-
tinuous suction equipment that was accessed on the wall
of each room via a plastic sterile secretion collector tube.
An anti-bacterial filter was used to avoid contamination by
the hospital vacuum net (Zammi, Rio de Janeiro, Brazil).
Because the pressure in the vacuum net is naturally unstable,
a pressure stabilizer device was specifically designed for this
purpose (Curavac VX 200, Ventrix Health Innovation, Brazil).
The equipment was regulated to provide a continuous pres-
sure of 120 mmHg. This device uses a system of springs to
restrain any increase in pressure over the established limit and
keep it stable when wall vacuum pressure decreases.
The dressing was changed twice per week in all patients
while they were under general anesthesia. When necessary,
surgical debridement was performed at the same time. Dur-
ing dressing changes, all disposable articles were discarded.
The pressure stabilizer device that was used in the study
group is composed of a permanent material that can be used
for many treatments.
Outcomes
The primary outcome used was the time (in days) neces-
sary to achieve a ‘‘ready for the surgery’’ condition, which
was defined as a wound bed with healthy granulation tissue
and without necrosis or purulent secretion (8).
The patient follow-up period started as soon as the first
debridement was performed and the NPWT dressings were
placed and continued until a surgery achieved definitive
wound closure.
The following were secondary outcomes:
1. Changes in wound bed area over time. The dimensions
of each wound were documented using digital photo-
graphy at each dressing change. The images were uploaded
and the wound area calculated using the National Institutes
of Health ImageJ software with the scale set using the ruler
in the image.
2. Granulation tissue growth: The percentage of the wound
bed that was composed of granulation tissue was cal-
culated in wound images by dividing the amount of red
tissue area by the total wound area.
3. Costs: The direct costs of each type of dressing were also
measured. In both groups, these costs included the cost
of supplies (e.g., suction canisters, catheters or drains,
tubing, gauze, and adhesive drapes). The following two
main cost analyses were performed: the costs associated
with each dressing exchange and the average cost of
treatment. The direct costs of dressing exchange were
recorded (i.e. the cost of inputs) for each of the treatments
applied in the USP and VAC groups. In the USP group,
the prices paid by the hospital for a 55 x 45 cm sterile
adhesive film, a zoobec sterile gauze, a urethral catheter
no. 16 and a 500 ml secretion collecting bottle were recorded.
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In the VAC group, the costs of the sponge kit and the
secretory collection bottle were recorded. To determine
the average cost of treatment, the cost of each dressing
change was multiplied by the number of exchanges per-
formed in each of the groups during the study period. The
prices were quoted on October 21, 2016 and obtained from
the hospital’s electronic stock control system.
Failure of intervention
Failure of therapy was recorded in any of the following
situations:
1. A dressing could not be maintained because of persistent
fluid or suction leaks. If, after two attempts at dressing
reinforcement during a 24-hour period, the seal could
not be maintained, the patient was considered a case of
intervention failure.
2. If a patient developed bleeding, invasive wound infec-
tion or sepsis, or a situation in which the dressing could
worsen the patient’s clinical condition, NPWTwas discon-
tinued and considered a failure.
3. If the patient died before the achieving a ‘‘ready for surgery’’
condition.
Randomization and blinding
To allocate the participants, a computer-generated list
was obtained using the website www.randomization.com.
The patients were randomized by the number sequence to
either the USP or VAC group in a 1:1 ratio in four blocks. The
allocations were printed and inserted into opaque, sealed,
numbered envelopes. A research assistant who was blind to
the allocation drew one envelope per consecutive patient and
then revealed the allocation to the assistant physician only at
the moment the patient was admitted for therapy.
The two methods used to perform NPWT were obviously
visually different, and it was therefore impossible to blind
either the therapists or the patients to the method of treat-
ment. However, the two researchers who used ImageJ to
perform the measurements used to evaluate wound closure
in each digital image were blinded to patient allocation.
Statistical methods
A per protocol analysis was performed to evaluate the
primary and secondary outcomes. Initially, all data were
recorded descriptively, as absolute numbers, frequencies, and
confidence intervals for categorical data and as the means and
standard deviations for continuous data. Pearson’s chi-squared
test was used for comparisons of categorical data, and Mann-
Whitney or Student’s t tests were used for comparisons of
continuous data between the groups. An alpha error of 0.05
was adopted as indicative of significance. SPSS 23 for Mac
software was used for the statistical analysis.
’ RESULTS
Participant flow, treatment failures and baseline
data
During the study period, 120 patients were assessed for
eligibility. Of these, 38 were excluded (20 who did not
meet eligibility criteria and 18 who were unable to consent).
Two further patients refused to participate. As shown in the
flow diagram presented in Figure 1, a total of 72 patients
(36 in each group) were enrolled in the study. Baseline demo-
graphics and clinical data were similar between the groups
and are listed in Table 1. A total of 19 wounds were analyzed
in the USP group, and 32 were analyzed in the VAC group.
Two patients died in the USP group as a result of multiple
organ failure during clinical care for severe trauma. No patient
in the VAC group died. It was not possible to maintain
vacuum pressure in 2 cases in the USP group and 1 case in
the VAC group. The following patients were lost: in the USP
group, 17 patients were lost due to: the hospital lacked
the supplies required to perform the dressing procedure in
the hospital (5 cases), the patient was transferred to another
setting and was lost to follow-up (8 cases), and it was impos-
sible to maintain vacuum (2 cases). In the VAC group, 2 cases
were lost to follow-up, and in 1 case, it was impossible to
maintain vacuum.
Primary outcome: time to heal
There were 19 wounds in the 17 patients in the USP group,
in which 15 had 1 wound, and 2 had 2 wounds each. The
VAC group consisted of 30 patients with 1 wound and
1 patient with 2 wounds for a total of 32 wounds. All wounds
in all patients were included in the analysis. The number
of days necessary to achieve a ‘‘ready for surgery’’ condi-
tion was similar across the 51 included wounds. In the USP
group, the 19 wounds took 9.6±4.5 days to heal, while in the
VAC group, the 32 wounds took 12.8±8.6 days to recover
(p=0.379) (Figure 2).
Secondary outcomes
1. Changes in wound bed area: there was an increase in wound
surface area in both groups. However, the rate of change
was not significantly different between the groups (1.13±
0.80 in the USP group and 1.12±0.80 in the VAC group;
p=0.934) (Figure 3).
2. Granulation tissue growth: There was an increase in granula-
tion tissue percentage in both groups. The rate of change
was 53.01% for USP and 44.18% for VAC. However, the rate
of change between the groups was not significantly differ-
ent (p=0.408). The percentage of granulation tissue growth
per day for the USP and VAC groups were: 5.79±2.93 and
5.06±5.15) (p=0.408; Figure 4).
3. Mean cost of treatment:
Cost of each dressing: The mean cost of supplies for each
dressing used in VAC therapy was US$ 513.29 (R$ 1,622.00).
The mean cost of supplies for each dressing changed per-
formed in USP therapy was US$ 8.22 (R$ 26.00). These
prices were quoted on October 21st 2016 by the Purchasing
Department of our hospital. The U.S. dollar exchange rate
was 3.16 (as of October 21st, 2016).
Mean cost of treatment: This metric was calculated as
the mean cost of the dressings multiplied by the mean
number of dressings applied. The total in the USP group
was US$ 15.15 (R$ 47.89), and the total in the VAC group
was US$ 872.59 (R$ 2,757.40). Tables 2 and 3 show that the
cost was significantly different between the groups.
’ DISCUSSION
Negative-pressure wound therapy (NPWT) was first described
in 1966 (9). Although various NPWT systems are currently
available on the market, their costs have limited their acces-
sibility in many institutions (2,6). More recently, researchers
have studied low-cost methods of performing NPWT (2,6,10,11).
In 2007, the University of São Paulo developed a low-cost
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NPWT based on a pressure stabilizer device. The experience
of the authors with this method was published in 2010 as
a case series (12). In the present study, we performed a
prospective, randomized clinical trial to compare the USP
method with another NPWT method that uses the VAC
system.
We chose to perform a non-inferiority trial based on the
expectation that the time necessary for the wound bed to
Figure 1 - Flow diagram of patient inclusion and exclusion.
Table 1 - Demographics and Clinical Characteristics.
Variable USP (n=19) VAC (n=32) p
Mean age (years) 34.7±15.1 33.4±16.1 0.603
Gender, male (%, n) 84% (16) 90% (29) 0.659
Trauma by traffic accidents* 94% 84% 0.392
Anatomical region (inferior limb) 93.8% 94.7% 0.885
Initial area (cm2) 80±55 105.7±106.3 0.711
*Car or motorcycle collision or pedestrian run over.
Figure 2 - Time necessary to achieve a ‘‘ready for the surgery’’
condition (days).
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improve (in days) would be longer in patients treated with
USP therapy than in those treated with a VAC System
(primary outcome). Wound bed area contraction and granula-
tion tissue growth were also assessed as secondary outcomes.
The USP group did indeed heal three days faster. Although
this was not a statistically significant difference, the USP
group presented less variability than the VAC group. In addi-
tion, USP and VAC were demonstrated to be equally effective,
showing that the USP system is non-inferior to the VAC
system, which is significantly more expensive. In a public
trauma center such as ours, this difference can result in huge
savings in resources that can therefore be used to treat more
patients. The cost of treatment in the USP group was approxi-
mately 2% of the cost in the VAC system.
This study replicates and extends the results of Dorafshar
et al. (6) and demonstrates that the two methods of NPWT
(USP and VAC) presented here achieved very similar results
with regard for increased granulation tissue. The wound area
was increased in both groups, probably as a result of the surgical
debridement required to prepare the wound bed. However, there
was no difference in wound area between the groups.
There was a higher prevalence of male patients in our
study, and this could be considered a limitation of our
study because there may be differences in wound healing
between the genders (13,14). This higher male prevalence
was expected because the patients in this study were
recruited in a trauma center, where the majority of victims
are males who were involved in traffic accidents. Still, we
observed no baseline difference between the groups with
regard for gender, and the male prevalence was the same in
both groups.
Another limitation that could be noted is the lack of blind-
ing, which raises the possibility of investigator bias. Patient
allocation could not be blinded because the two devices
are clearly different from the point of view of both the
researchers and the patients. We minimized this risk by
blinding the two evaluators who used ImageJ software to
measure the wound area and determine the percentage of
area with granulation tissue.
The total number of wound treatments analyzed in the
study did not reach the estimated sample size, mainly because
we had difficulties with the supply of required materials in our
public hospital. Additionally, some patients were first admitted
in our hospital (a referral center for trauma) but were later
transferred to another hospital, resulting in loss to follow-up.
However, even if the length of the study had been extended
to increase the sample size, it would not have influenced the
primary outcome result. The similarity between the two eval-
uated methods of performing NPWT has also been reported by
multiple authors in different countries (2,6,10,11).
The USP method of performing NPWT is non-inferior to
the VAC System for treating complex traumatic injuries.
’ ACKNOWLEDGMENTS
The study was supported by ﬁnancial assistance from CNPq (Conselho
Nacional de Desenvolvimento Cientíﬁco e Tecnológico), grant 400.804/
2014-0.
’ AUTHOR CONTRIBUTIONS
Kamamoto F was responsible for the study design, data collection and
interpretation, manuscript drafting, and approval of the ﬁnal version of the
manuscript for publication. Lima AL was responsible for the study design,
data collection and interpretation, and approval of the ﬁnal version of the
manuscript for publication. Mattar-Junior R was responsible for the study
design, data collection, approval of the ﬁnal version of the manuscript for
publication. de Rezende MR, Leonhardt MC, Kojima KE and dos Santos
CC were responsible for the data collection and analysis, and approval of
the ﬁnal version of the manuscript for publication.
’ REFERENCES
1. Krug E, Berg L, Lee C, Hudson D, Birke-Sorensen H, Depoorter M,
et al. Evidence-based recommendations for the use of Negative Pressure
Wound Therapy in traumatic wounds and reconstructive surgery: steps
Figure 3 - Changes in wound bed area (%).
Figure 4 - Granulation tissue increase (%).
Table 2 - Cost of dressings (US$/day).
Variable USP (n=18) VAC (n=32)
Mean cost per dressing US$ 8.22 US$ 513.29
Mean treatment cost US$ 15.15 US$ 872.59
Table 3 - Comparative cost of dressings (US$/day).
VAC initial VAC post USP initial USP post
Area 105.71074 93.013 80.00431 73.41
Granulation 38.68743 82.86846 34.03333 87.03500
Cost 2757.4000 47.8947
741
CLINICS 2017;72(12):737-742 A new negative-pressure wound therapy device
Kamamoto F et al.
towards an international consensus. Injury. 2011;42 Suppl 1:S1-12,
http://dx.doi.org/10.1016/S0020-1383(11)00041-6.
2. Chaput B, Garrido I, Eburdery H, Grolleau JL, Chavoin JP. Low-cost
Negative-pressure Wound Therapy Using Wall Vacuum: A 15 Dollars
by Day Alternative. Plast Reconstr Surg Glob Open. 2015;3(6):e418,
http://dx.doi.org/10.1097/GOX.0000000000000347.
3. Yang CC, Chang DS, Webb LX. Vacuum-assisted closure for fasciotomy
wounds following compartment syndrome of the leg. J Surg Orthop Adv.
2006;15(1):19-23.
4. Zannis J, Angobaldo J, Marks M, DeFranzo A, David L, Molnar J, et al.
Comparison of fasciotomy wound closures using traditional dressing
changes and the vacuum-assisted closure device. Ann Plast Surg. 2009;
62(4):407-9, http://dx.doi.org/10.1097/SAP.0b013e3181881b29.
5. Wong LK, Nesbit RD, Turner LA, Sargent LA. Management of a circum-
ferential lower extremity degloving injury with the use of vacuum-assisted
closure. South Med J. 2006;99(6):628-30.
6. Dorafshar AH, Franczyk M, Gottlieb L, Wroblewski KE, Lohman RF.
A prospective randomized trial comparing subatmospheric wound therapy
with a sealed gauze dressing and the standard vacuum-assisted closure
device. Ann Plast Surg. 2012;69(1):79-84, http://dx.doi.org/10.1097/SAP.
0b013e318221286c.
7. Kim JJ, Franczyk M, Gottlieb LJ, Song DH. Cost-effective Alternative
for Negative-pressure Wound Therapy. Plast Reconstr Surg Glob Open.
2017;5(2):e1211, http://dx.doi.org/10.1097/GOX.0000000000001211.
8. Mouës CM, van den Bemd GJ, Meerding WJ, Hovius SE. An economic
evaluation of the use of TNP on full-thickness wounds. J Wound Care.
2005;14(5):224-7, http://dx.doi.org/10.12968/jowc.2005.14.5.26776.
9. Mirazimov BM. [Free skin graft of the foot with vacuum preparation of
the wound surface]. Ortop Travmatol Protez. 1966;27(10):19-22.
10. Fenn CH, Butler PE. Abdominoplasty wound-healing complications:
assisted closure using foam suction dressing. Br J Plast Surg. 2001;
54(4):348-51, http://dx.doi.org/10.1054/bjps.2000.3552.
11. Mansoor J, Ellahi I, Junaid Z, Habib A, Ilyas U. Clinical evaluation of
improvised gauze-based negative pressure wound therapy in military
wounds. Int Wound J. 2015;12(5):559-63, http://dx.doi.org/10.1111/iwj.12164.
12. Kamamoto F, Lima Jr JE, Batista BN, Zilli B, Ferreira MC. Experiência do
Hospital Universitário da USP com o curativo de pressão negativa tópica
para o tratamento de feridas complexas. Rev Bras Cir Plast. 2010;25 (sup1): 74.
Available from: http://www.rbcp.org.br/details/684/experiencia-do-hospi
taluniversitario-da-usp-com-o-curativo-de-pressao-negativa-topica-para-otrat
amento-de-feridas-complexas. Accessed in 2017 (Apr 25).
13. Engeland CG, Sabzehei B, Marucha PT. Sex Hormones and Mucosal
Wound Healing. Brain Behav Immun. 2009;23(5):629-35, http://dx.doi.
org/10.1016/j.bbi.2008.12.001.
14. Wehrens KM, Arnoldussen CW, Booi DI, van der Hulst RR. Clinical
Evaluation of Wound Healing in Split-Skin Graft Donor Sites Using
Microscopic Quantification of Reepithelialization. Adv Skin Wound Care.
2016;29(6):254-60, http://dx.doi.org/10.1097/01.ASW.0000481179.88936.d4.
742
A new negative-pressure wound therapy device
Kamamoto F et al.
CLINICS 2017;72(12):737-742
